130 related articles for article (PubMed ID: 15695381)
41. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
[TBL] [Abstract][Full Text] [Related]
42. Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner.
Schneikert J; Grohmann A; Behrens J
Hum Mol Genet; 2007 Jan; 16(2):199-209. PubMed ID: 17189293
[TBL] [Abstract][Full Text] [Related]
43. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
44. APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation.
Abal M; Obrador-Hevia A; Janssen KP; Casadome L; Menendez M; Carpentier S; Barillot E; Wagner M; Ansorge W; Moeslein G; Fsihi H; Bezrookove V; Reventos J; Louvard D; Capella G; Robine S
Gastroenterology; 2007 Jun; 132(7):2448-58. PubMed ID: 17570218
[TBL] [Abstract][Full Text] [Related]
45. Loss of heterozygosity and nonsense mutation in Apc in azoxymethane-induced colonic tumours in min mice.
Møllersen L; Paulsen JE; Alexander J
Anticancer Res; 2004; 24(5A):2595-9. PubMed ID: 15517863
[TBL] [Abstract][Full Text] [Related]
46. Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.
Samuel MS; Suzuki H; Buchert M; Putoczki TL; Tebbutt NC; Lundgren-May T; Christou A; Inglese M; Toyota M; Heath JK; Ward RL; Waring PM; Ernst M
Gastroenterology; 2009 Sep; 137(3):902-13, 913.e1-11. PubMed ID: 19454286
[TBL] [Abstract][Full Text] [Related]
47. Identification of novel modifier loci of Apc Min affecting mammary tumor development.
Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR
Cancer Res; 2007 Dec; 67(23):11226-33. PubMed ID: 18056448
[TBL] [Abstract][Full Text] [Related]
48. A mouse model for cyclin E-dependent genetic instability and tumorigenesis.
Loeb KR; Kostner H; Firpo E; Norwood T; D Tsuchiya K; Clurman BE; Roberts JM
Cancer Cell; 2005 Jul; 8(1):35-47. PubMed ID: 16023597
[TBL] [Abstract][Full Text] [Related]
49. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
50. The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse.
Hulboy DL; Gautam S; Fingleton B; Matrisian LM
Oncol Rep; 2004 Jul; 12(1):13-7. PubMed ID: 15201952
[TBL] [Abstract][Full Text] [Related]
51. A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine.
Reed KR; Meniel VS; Marsh V; Cole A; Sansom OJ; Clarke AR
BMC Cancer; 2008 Jun; 8():162. PubMed ID: 18533991
[TBL] [Abstract][Full Text] [Related]
52. Targeted inactivation of p53 in human cells does not result in aneuploidy.
Bunz F; Fauth C; Speicher MR; Dutriaux A; Sedivy JM; Kinzler KW; Vogelstein B; Lengauer C
Cancer Res; 2002 Feb; 62(4):1129-33. PubMed ID: 11861393
[TBL] [Abstract][Full Text] [Related]
53. Mammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency.
Bennett LM; McAllister KA; Ward T; Malphurs J; Collins NK; Seely JC; Davis BJ; Wiseman RW
Toxicol Pathol; 2001; 29(1):117-25. PubMed ID: 11215675
[TBL] [Abstract][Full Text] [Related]
54. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias.
Moser AR; Mattes EM; Dove WF; Lindstrom MJ; Haag JD; Gould MN
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8977-81. PubMed ID: 8415640
[TBL] [Abstract][Full Text] [Related]
55. The ROSA26 LacZ-neo(R) insertion confers resistance to mammary tumors in Apc(Min/+) mice.
Kohlhepp RL; Hegge LF; Moser AR
Mamm Genome; 2001 Aug; 12(8):606-11. PubMed ID: 11471054
[TBL] [Abstract][Full Text] [Related]
56. The DNA resection protein CtIP promotes mammary tumorigenesis.
Reczek CR; Shakya R; Miteva Y; Szabolcs M; Ludwig T; Baer R
Oncotarget; 2016 May; 7(22):32172-83. PubMed ID: 27058754
[TBL] [Abstract][Full Text] [Related]
57. Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.
Heinlein C; Krepulat F; Löhler J; Speidel D; Deppert W; Tolstonog GV
Int J Cancer; 2008 Apr; 122(8):1701-9. PubMed ID: 18092324
[TBL] [Abstract][Full Text] [Related]
58. Strain-dependent susceptibility to radiation-induced mammary cancer is a result of differences in epithelial cell sensitivity to transformation.
Ullrich RL; Bowles ND; Satterfield LC; Davis CM
Radiat Res; 1996 Sep; 146(3):353-5. PubMed ID: 8752316
[TBL] [Abstract][Full Text] [Related]
59. Genetic mechanisms in Apc-mediated mammary tumorigenesis.
Kuraguchi M; Ohene-Baah NY; Sonkin D; Bronson RT; Kucherlapati R
PLoS Genet; 2009 Feb; 5(2):e1000367. PubMed ID: 19197353
[TBL] [Abstract][Full Text] [Related]
60. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.
Maekawa T; Sano Y; Shinagawa T; Rahman Z; Sakuma T; Nomura S; Licht JD; Ishii S
Oncogene; 2008 Feb; 27(8):1045-54. PubMed ID: 17700520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
